NewLeaf Symbiotics
PrivateLast Round
Series D
Dec 19, 2023
Total Funding Raised
$141M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NewLeaf Symbiotics operates in Frontier & Industrial Tech and is based in Saint Louis, Michigan. Its latest recorded funding round was a Series D round in December 2023.
NewLeaf Symbiotics is an agricultural biotechnology company that develops and commercializes sustainable agricultural products based on beneficial bacteria to help farmers fight plant disease and increase crop yields.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NewLeaf Symbiotics Comparables
Compare NewLeaf Symbiotics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioConsortia, Inc. | 81% | |
| Locus Fermentation Solutions | 78% | |
| Sound | 78% |
For institutional investors. Book with your work email.
NewLeaf Symbiotics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 19, 2023 | ||||
| Series D | Dec 1, 2020 | ||||
| Series D | Feb 24, 2020 | ||||
| Series C | Sep 7, 2017 | ||||
| Series B | Sep 17, 2014 | ||||
Series A | Jan 10, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NewLeaf Symbiotics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RockPort Capital Partners | Series D, Series A, Series C, Series B |
| Open Prairie | Series A, Series C, Series B |
| Open Prairie Ventures | Series C, Series B, Series A |
| Re:food | Series D |
| The Yard Ventures | Series C |
| Lewis & Clark Partners | Series C |
| Lewis & Clark Ventures | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 93% MoM.
- Jul 1, 2026
Launching a new biostimulant for vegetable transplants on July 1, 2026.
For institutional investors. Book with your work email.
NewLeaf Symbiotics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NewLeaf Symbiotics's valuation, stock price, and market status.
Is NewLeaf Symbiotics a public or private company?
NewLeaf Symbiotics is a private company.
What is the current stock price of NewLeaf Symbiotics?
NewLeaf Symbiotics is a private company, so its shares have no public market price. Caplight tracks NewLeaf Symbiotics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NewLeaf Symbiotics worth (valuation)?
Valuation information for NewLeaf Symbiotics is not publicly available.
Can I buy NewLeaf Symbiotics stock?
NewLeaf Symbiotics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NewLeaf Symbiotics's last funding round?
NewLeaf Symbiotics's most recent funding round was Series D on December 19, 2023.
Who are the main investors in NewLeaf Symbiotics?
Key investors in NewLeaf Symbiotics include Open Prairie Ventures, Re:food, S2G Investments, Leaps by Bayer, Otter Capital.
Will NewLeaf Symbiotics IPO soon?
No public IPO plans have been announced for NewLeaf Symbiotics.
How can I track NewLeaf Symbiotics secondary market activity?
Caplight tracks bids, offers, and trades in NewLeaf Symbiotics's shares on secondary markets.